Kopran Ltd. - Quarterly/Annual Result Disclosures and Notes dated 31 Mar 2021
Auditor and Management Disclosures and Notes for the annual results dated 31 Mar 2021
Notes:-
1) The above Statement of consolidated and standalone audited financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act 2013, read with Companies (Indian Accounting Standards) Rules, 2015, as amended and other accounting principles generally accepted in India and guidelines issued by Securities and Exchange Board of India (SEBI). There is no minority interest.
2) The above Statement of consolidated and standalone audited financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on May 27, 2021. The Statutory Auditors report do not have any modification/ qualification. Figures for the last quarters ended March 31, 2020 and March 31, 2021 represent the balancing figures between the audited figures for the full financial year and the published year to date reviewed figures upto third quarter of the respective financial year.
3) For financial year 2021, the Board has recommended a final dividend of Rs. 1.5/- (par value of Rs. 10/- each) per equity share. This payment is subject to the approval of shareholders in the Annual General Meeting (AGM) of the Company. An interim dividend of Rs. 1.5/- (par value of ^10/- each) per equity share was declared on October 28, 2020 and the same was paid on November 11, 2020.
4) Under the Remission of Duties and Taxes on Export Products (RoDTEP) Scheme, the Company is eligible to claim refunds of embedded taxes and duties. All the items previously under the Merchandise Export Incentives Scheme (MEIS) are now under the purview of the RoDTEP Scheme. The said Scheme is effective from January 1, 2021 However, the incentive rates are yet to be notified by the authorities and for the period January 1, 2021 to March 31, 2021, the Company has not accounted for any income in this regard.
5) The Corporate Affairs Committee, a Board Committee of the Company in its meeting held on 12th February, 2021, has forfeited 1,996 partly paid-up Equity Shares of Rs.10 each as the call amount outstanding at the rate of Rs. 20 per share has (consisting of Rs.5 towards face value and Rs.15 towards securities premium) has remained unpaid.
6) The Company and the subsidiaries (together referred to as "the Group") are engaged primarily in the Pharmaceuticals business and there are no separate reportable segments as per Ind AS 108 on " Operating Segment Reporting".
7) The Group has not experienced any significant impact on its operations, supply chain and recoverability of carrying amounts of financial and non-financial assets due to COVID 19 pandemic. As the pandemic continues to evolve, the Group will continue to closely monitor for any material changes to future economic conditions.
8) Figures for the previous period have been regrouped or reclassified, wherever necessary to make them comparable with the figures of the current period.